Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese ...
Mentari Therapeutics, a privately held biotechnology enterprise dedicated to preventing migraines, has successfully secured ...
Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...
Ruypeptide Biotechnology Co., Ltd.** is expanding its international presence by strengthening its biotechnology research capabilities, manufacturing capacity, and global customer support as demand for ...
One offers global diversification and higher income; the other delivers focused biotech exposure with lower costs and ...
Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.
Innovative Pharmaceutical Biotech (HK:0399) has released an update. Innovative Pharmaceutical Biotech Limited has entered into a Memorandum of Understanding to potentially acquire a majority stake in ...
Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino?
Zacks Investment Research on MSN
Revvity to launch Signals for Startups for emerging biotech companies
Revvity, Inc. RVTY recently announced the launch of Signals for Startups, a new program to help early-stage biotechnology ...
It's been a volatile year for the company, but don't let that scare you away.
Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.
PJP delivers lower volatility and higher income with concentrated pharma exposure, while XBI offers broader biotech growth at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results